Parataxis Korea, Inc. (KOSDAQ:288330)
South Korea · Delayed Price · Currency is KRW 416.00
-13.00 (-3.03%)
At close: Apr 7, 2026
Parataxis Korea Market Cap
Parataxis Korea has a market cap or net worth of 44.13 billion as of May 19, 2026. Its market cap has decreased by -82.88% in one year.
Market Cap
44.13B
Enterprise Value
42.20B
Revenue
9.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
416.00
Market Cap Chart
Since December 20, 2019, Parataxis Korea's market cap has decreased from 300.15B to 44.13B, a decrease of -85.30%. That is a compound annual growth rate of -26.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 44.13B | -43.78% |
| Dec 30, 2025 | 78.49B | -58.48% |
| Dec 30, 2024 | 189.04B | 158.57% |
| Dec 28, 2023 | 73.11B | -68.32% |
| Dec 29, 2022 | 230.80B | -17.53% |
| Dec 30, 2021 | 279.85B | 0.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 62.64B |
| HLB Pep | 61.34B |
| Psomagen | 59.73B |
| J2KBIO | 59.24B |
| Aptamer Sciences | 51.97B |
| ADBiotech | 48.81B |
| Epibiotech | 48.21B |
| Poongjeon Pharmacy CO.,LTD. | 40.98B |